年轻健康成人FIB-4评分与终末期肝病的关联:一项全国性回顾性研究
该回顾性研究利用全国社区和医院数据库,纳入2005-2020年间18-40岁、计算过FIB-4评分的年轻成人,评估FIB-4评分与终末期肝病(ESLD)发病的关联。共观察到430例ESLD事件,每点FIB-4评分与ESLD风险增加相关(校正HR 2.21,95%CI 1.91-2.56)。
要点
- 年轻健康成人FIB-4评分与终末期肝病发病风险相关。
- FIB-4评分每增加1点,ESLD风险校正HR为2.21(95%CI 1.91-2.56)。
- FIB-4评分≥99百分位者较5-49百分位者ESLD风险增加760%。
核心结论
- 在年轻健康成人中,FIB-4评分与终末期肝病(ESLD)发病风险增加相关。
研究设计与样本
- 回顾性研究,使用全国社区和医院数据库,纳入2005-2020年间18-40岁、计算过FIB-4评分的年轻成人,排除研究前或期间诊断肝转移或除MASLD外的慢性肝病者。
- 主要结局为首次诊断肝硬化、肝硬化相关并发症或肝细胞癌。
- 采用Cox比例风险模型,FIB-4评分按百分位数分类。
主要发现
- 共观察到430例ESLD事件,共计11,057,421人年(诊断时平均年龄30.0±5.3岁)。
- 与FIB-4评分在5-49百分位者相比,75-94百分位、95-98百分位和≥99百分位者发生ESLD的可能性分别增加35%、140%和760%。
- FIB-4评分每增加1点,ESLD发病风险校正HR为2.21(95%CI 1.91-2.56)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Metabolic dysfunction-associated steatotic liver disease (MASLD) is highly prevalent and underdiagnosed among young healthy adults, with or without metabolic syndrome. This study assessed whether the Fibrosis-4 Index (FIB-4) in young healthy adults is associated with incident end-stage liver disease (ESLD). METHODS: This retrospective study was conducted using a nationwide community and hospital database. Included were young adults, ages 18-40 years, with a FIB-4 score calculated during 2005-2020. People diagnosed with liver metastasis or chronic liver disease, other than MASLD, before or during the study, were excluded. The primary outcome was the first diagnosis of cirrhosis, cirrhosis-related complications, or hepatocellular carcinoma. Cox proportional models were applied, with FIB-4 score categorized by percentiles. RESULTS: There were 430 incident cases of ESLD in 11,057,421 person-years (mean age at diagnosis 30.0 ± 5.3 years). FIB-4 score was associated with incident ESLD. After adjusting for multiple confounders, people with FIB-4 in the 75th-94th, 95th-98 th , and ≥ 99th percentiles were 35%, 140%, and 760% more likely to develop ESLD, respectively, compared with people with FIB-4 score in the 5th-49th percentiles. Each point of FIB-4 score was associated with a 2.2-fold greater risk of incident ESLD (adjusted hazard ratio 2.21, 95% confidence interval 1.91-2.56). DISCUSSION: FIB-4 score is associated with increased risk of ESLD in young healthy adults.
引用
- Meron MK, Hornik-Lurie T, Rotman-Pikielny P, et al. FIB-4 Score in Young Healthy Adults and Its Association With End Stage Liver Disease: A Nationwide Retrospective Study. Am J Gastroenterol. 2025. PMID: 40560189. doi:10.14309/ajg.0000000000003605
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。